
Study Period | 2019 - 2030 |
Base Year For Estimation | 2024 |
Market Size (2025) | USD 4.85 Billion |
Market Size (2030) | USD 7.42 Billion |
CAGR (2025 - 2030) | 8.89 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Nucleic Acid Isolation & Purification Market Analysis
The Nucleic Acid Isolation And Purification Market size is estimated at USD 4.85 billion in 2025, and is expected to reach USD 7.42 billion by 2030, at a CAGR of 8.89% during the forecast period (2025-2030).
The nucleic acid isolation and purification market is experiencing significant transformation driven by increasing investment in biotechnology infrastructure and research capabilities. According to the India Bioeconomy Report 2022, the biotech sector achieved a valuation of USD 80 billion in 2021 and is projected to expand to USD 150 billion by 2025, highlighting the robust growth trajectory of the broader biotechnology industry. This expansion has led to increased demand for advanced nucleic acid isolation and purification technologies across research institutions and biotechnology companies. The sector is witnessing substantial private equity investments and government funding initiatives, particularly in emerging markets, which is creating new opportunities for market expansion and technological innovation.
The industry landscape is being reshaped by strategic investments in manufacturing capabilities and research infrastructure. In January 2023, Agilent Technologies made a significant investment of approximately USD 725 million to double its manufacturing capacity for therapeutic nucleic acids, responding to growing market demands. This trend of capacity expansion is being mirrored across the nucleic acid industry, with several companies focusing on establishing state-of-the-art facilities. The emphasis on automated solutions and high-throughput systems is driving innovation in product development, with manufacturers introducing more efficient and reliable purification technologies.
The nucleic acid isolation and purification market size is witnessing a surge in demand driven by advances in genetic research and precision medicine applications. According to the American Cancer Society's January 2023 report, approximately 1,958,310 new cancer cases are projected to occur in the United States by the end of 2023, highlighting the growing need for nucleic acid isolation and purification technologies in clinical research and diagnostic laboratories, particularly for applications in oncology and genetic disorders.
The industry is benefiting from sustained growth in research funding and institutional support. The National Institutes of Health (NIH) has projected an increase in genetics research funding from USD 11,615 million in FY 2022 to USD 12,445 million by 2024, demonstrating strong governmental commitment to advancing genetic research. This financial backing is facilitating the development of novel nucleic acid extraction techniques, while also supporting the adoption of advanced automated systems in research institutions. The trend towards increased research funding is particularly evident in emerging economies, where governments are establishing dedicated biotechnology research centers and providing incentives for industry development.
Nucleic Acid Isolation & Purification Market Trends
Rapid Technological Advancements
The DNA RNA isolation and DNA RNA purification market is experiencing significant growth driven by continuous technological innovations that enhance process efficiency, accuracy, and scalability. Advanced automated systems have revolutionized the field by streamlining nucleic acid extraction processes, with new platforms reducing touchpoints by up to 80% compared to traditional spin column products. For instance, Beckman Coulter Life Sciences' EMnetik System, launched in 2023, has drastically reduced the time required for PCR cleanup from 30 minutes to just 16 minutes while slashing process touchpoints from 300 to merely 50, demonstrating the remarkable efficiency gains achieved through automation.
Magnetic bead-based technologies have emerged as a game-changing innovation in DNA RNA purification. According to industry sources in 2023, magnetic beads offer a quick, simple, and more efficient way to separate DNA than traditional techniques, particularly excelling at recovering small particles (0.05–1 micrometer) in the presence of biological debris. The technology's advantages include higher yield, improved purity, and compatibility with various sample types. Additionally, single-step nucleic acid extraction methods have been developed to shorten isolation time and increase yield, as evidenced by BioEcho Life Sciences' receipt of patents for their EchoLUTION technology from both the United States Patent and Trademark Office and the Japan Patent Office in 2023.
Wide-range Applications of Nucleic Acid Testing in Diagnostics
The expanding applications of nucleic acid testing in diagnostics have become a crucial driver for market growth, particularly in areas such as infectious disease diagnosis, genetic testing, cancer diagnostics, and point-of-care testing. Nucleic acid testing has revolutionized cancer diagnostics by enabling the detection of specific genetic mutations and alterations in tumor samples, facilitating early detection, prognosis determination, and treatment selection. The technology's importance is underscored by recent statistics, with the American Cancer Society projecting 1,958,310 new cancer cases in the United States by the end of 2023, creating substantial demand for effective nucleic acid-based diagnostic solutions.
Recent advancements have led to the development of innovative diagnostic approaches, such as nucleic-acid-based lateral flow assays (NABLFA) that combine molecular detection with immunochemical visualization principles. These assays have emerged as valuable tools for cancer diagnosis, even at low biomarker concentrations, and present an appealing method for point-of-care testing in resource-limited regions. The technology's versatility extends to infectious disease diagnosis, where nucleic acid testing plays a vital role in detecting and identifying pathogens directly from patient samples, enabling rapid and accurate diagnosis through specific genetic material identification.
Rise in the R&D Funding in Biotechnology
The substantial increase in research funding for biotechnology and genetic research has emerged as a significant driver for the isolation and purification of nucleic acids market. According to the National Center for Health Statistics (NCHS), research funding in genetics is projected to increase from USD 11,615 million in FY 2022 to USD 12,445 million by 2024, while research investments in genetic testing are expected to rise from USD 214 million in 2022 to USD 237 million by 2024. This increased funding directly impacts the demand for purification of nucleic acids products, as these are essential tools in genetic research and biotechnology applications.
The biotechnology sector has witnessed remarkable growth in investments, with significant funding being directed toward research and development activities. For instance, in 2023, the Board of the California Institute for Regenerative Medicine (CIRM) granted funding of approximately USD 89 million to pharmaceutical and biotechnology companies to support stem cell and gene therapy-based projects. Additionally, major companies are making substantial investments in the field, as evidenced by Agilent Technologies' USD 725 million investment in 2023 to double its manufacturing capacity for therapeutic nucleic acids. These investments reflect the growing importance of nucleic acid-based research and development in advancing biotechnology applications, driving the demand for isolation and purification technologies.
Segment Analysis: By Technology
Column-based Purification Segment in Nucleic Acid Isolation and Purification Market
Column-based purification technology holds a dominant position in the nucleic acid isolation and purification market, commanding approximately 41% market share in 2024. This significant market presence is attributed to the increasing usage of column-based purification methods for nucleic acid extraction, particularly in genomics research. The technology's popularity stems from its ability to quickly purify nucleic acids with high yield and purity without contamination. Recent developments include the introduction of advanced silica-based column purification processes that facilitate fast extractions with good yields of high-quality DNA/RNA, making it particularly successful in viral RNA isolation. The segment's growth is further supported by ongoing product launches and technological advancements by major market players focusing on enhancing extraction efficiency and throughput capabilities.

Magnetic Bead-based Purification Segment in Nucleic Acid Isolation and Purification Market
The DNA magnetic bead purification segment is projected to experience the fastest growth rate of approximately 10% during the forecast period 2024-2029. This accelerated growth is driven by the technology's superior advantages over traditional purification methods, particularly in recovering better-quality RNA due to the absence of centrifugation steps that can cause nucleic acids to break. The segment's expansion is further fueled by increasing applications in various nucleic acid isolation procedures and the rising adoption of automated platforms. Recent technological innovations in magnetic bead chemistry and the development of more efficient isolation protocols have significantly enhanced the segment's appeal. The technology's ability to handle high-throughput applications and its compatibility with automation platforms has made it increasingly attractive for both research and clinical applications.
Remaining Segments in Technology Segmentation
The reagent-based purification and other technologies segments continue to play vital roles in the nucleic acid isolation and purification market. Reagent-based purification, which includes organic extraction procedures such as cesium chloride/ethidium bromide density gradient centrifugation and phenol-chloroform extraction methods, remains a preferred choice among research laboratories for DNA and RNA purification. The other technologies segment, encompassing emerging methods like chelating resins isolation, magnetic disk technology, and non-organic salt precipitation isolation/purification, contributes to market diversity by offering alternative solutions for specific applications. These segments collectively provide researchers with a comprehensive toolkit for addressing various nucleic acid isolation challenges across different sample types and experimental conditions.
Segment Analysis: By Product
Kits and Reagents Segment in Nucleic Acid Isolation and Purification Market
The DNA purification kits market dominates the nucleic acid isolation and purification market, commanding approximately 73% market share in 2024. This significant market position is driven by the increasing product launches and agreements by major market players to expand their product portfolios. The segment's growth is further supported by the rising demand for specialized kits for various applications, including DNA/RNA extraction from different sample types. The widespread adoption of these products in research laboratories, pharmaceutical companies, and diagnostic centers has solidified their market leadership. Additionally, the continuous development of innovative extraction and purification technologies has led to more efficient and reliable kits, further strengthening their market position.
Equipment Segment in Nucleic Acid Isolation and Purification Market
The equipment segment is projected to experience the fastest growth in the nucleic acid isolation and purification market, with an estimated CAGR of approximately 10% from 2024 to 2029. This accelerated growth is primarily attributed to the increasing adoption of automated DNA/RNA purification and extraction platforms in various hospitals and academic research institutes. The segment's expansion is further driven by technological advancements in automated systems, which offer higher throughput, improved reproducibility, and reduced risk of contamination. The growing demand for efficient and reliable nucleic acid isolation equipment, particularly in large-scale research and diagnostic applications, continues to fuel this segment's rapid growth. Additionally, the increasing focus on reducing manual handling and improving workflow efficiency has led to greater investments in automated isolation and purification systems.
Remaining Segments in Product Segmentation
The other products segment, which includes solutions sold individually with reagents and kits, such as buffers, enzymes, plasticware, and glassware, plays a supporting role in the nucleic acid isolation and purification market. These products are essential components in nucleic acid isolation and purification procedures, particularly in research and diagnostic laboratories. The segment's importance is underscored by the growing usage of equipment consumables and other glassware in various isolation and purification procedures. While this segment may represent a smaller portion of the market, it remains crucial for maintaining the integrity and efficiency of nucleic acid isolation processes, providing necessary tools and materials for successful experimental outcomes.
Segment Analysis: By Application
Plasmid DNA Isolation and Purification Segment in Nucleic Acid Isolation and Purification Market
The Plasmid DNA Isolation and Purification segment continues to dominate the global nucleic acid isolation and purification market, holding approximately 18% market share in 2024. This segment's leadership position is primarily driven by the increasing research studies coupled with product launches by major market players. The segment's prominence is further reinforced by the growing demand for plasmid DNA in various applications, including gene therapy development and vaccine production. For instance, BioNTech SE's completion of its first proprietary plasmid DNA manufacturing facility in Marburg, Germany, demonstrates the increasing focus on plasmid DNA production capabilities. The facility's establishment aims to independently manufacture plasmid DNA for clinical product candidates and commercial products in cancer and infectious diseases, highlighting the segment's crucial role in advancing therapeutic developments.
Genomic DNA Isolation and Purification Segment in Nucleic Acid Isolation and Purification Market
The Genomic DNA Isolation and Purification segment is emerging as the fastest-growing segment, projected to expand at approximately 10% CAGR from 2024 to 2029. This remarkable growth is attributed to the rising usage of genomic DNA isolation and purification methods in various research applications and the increasing initiatives by key market players. The segment's growth is further propelled by technological advancements in DNA extraction methods, such as the development of automated systems for ultra-high molecular weight DNA isolation. The collaboration between Hamilton and Bionano Genomics for developing the Long String VANTAGE system exemplifies the industry's focus on automating genomic DNA extraction processes. Additionally, the segment's growth is supported by the expanding applications of genomic DNA analysis in personalized medicine and genetic research.
Remaining Segments in Nucleic Acid Isolation and Purification Market by Application
The market encompasses several other significant segments, including Total RNA Isolation and Purification, Blood DNA Isolation and Purification, mRNA Isolation and Purification, microRNA Isolation and Purification, and PCR Clean-up. The Total RNA segment maintains its importance in molecular biology and genetics research, while the Blood DNA segment serves crucial diagnostic applications in healthcare settings. The mRNA segment has gained prominence due to its role in vaccine development and therapeutic applications, while microRNA isolation continues to be vital for cancer research and biomarker discovery. The PCR Clean-up segment plays a supporting role in ensuring the quality of downstream applications. Each of these segments contributes uniquely to the market's diversity and serves specific research and diagnostic needs across various applications in life sciences.
Segment Analysis: By End User
Hospitals Segment in Nucleic Acid Isolation and Purification Market
The hospitals segment dominates the nucleic acid isolation and purification market, commanding approximately 32% of the total market share in 2024. This significant market position is attributed to hospitals being major healthcare service providers managing diverse patient populations with different diseases. Almost every hospital maintains a dedicated pathology department that extensively uses nucleic acid isolation and purification products for pathogen isolation and detection in diseased individuals to administer specific treatments. The segment's dominance is further strengthened by substantial government investments worldwide to improve healthcare infrastructure, especially in developing nations. Additionally, hospitals are increasingly establishing dedicated research centers and molecular pathology laboratories, such as hereditary cancer clinics and genomics laboratories, which extensively utilize nucleic acid isolation and purification products for various diagnostic and research applications. The segment's robust growth is also driven by the high influx of patients and the critical role of hospitals in national healthcare infrastructure.
Academic and Research Institutes Segment in Nucleic Acid Isolation and Purification Market
The academic and research institutes segment represents a vital component of the market, with significant growth potential driven by increasing research funding and collaborative initiatives. These institutes are actively engaged in research and development activities for novel methods of screening, diagnosis, and treatment of diseases using genetic materials like DNA and RNA. The segment's growth is fueled by substantial research funding from organizations like the National Institutes of Health (NIH) and various government bodies for genetics and biotechnology research. These institutes also play a crucial role in training and educating students, technicians, and other stakeholders in efficient isolation and purification of genetic material for different applications such as pathogen identification, classification, quantification, and analysis of genetic material types. The expansion of research facilities and establishment of new academic institutes globally further contributes to the segment's growth trajectory.
Remaining Segments in End User Market
The pharmaceutical/biotechnology industry and other end users segments complete the market landscape, each bringing unique contributions to the overall market dynamics. The pharmaceutical/biotechnology industry segment is particularly significant due to its involvement in drug discovery, development, and large-scale production of therapeutics requiring sterile environments and precise nucleic acid isolation procedures. This segment is characterized by heavy investments in research and development of cell and gene therapy, nucleic acid vaccines, and mRNA-based therapeutics. The other end users segment, which includes diagnostic clinics, laboratories, and contract development manufacturing organizations (CDMOs), plays a crucial role in providing specialized services and supporting the broader healthcare ecosystem through independent testing and research capabilities. These segments collectively contribute to the market's diversity and comprehensive coverage of various applications in nucleic acid isolation and purification.
Nucleic Acid Isolation and Purification Market Geography Segment Analysis
Nucleic Acid Isolation and Purification Market in North America
The North American nucleic acid isolation and purification market demonstrates robust growth driven by advanced research infrastructure and significant investments in genomics research. The region benefits from the presence of major biotechnology companies, research institutions, and healthcare facilities across the United States, Canada, and Mexico. The market is characterized by high adoption rates of automated nucleic acid extraction systems and increasing demand for molecular diagnostic testing. The presence of well-established healthcare infrastructure and favorable reimbursement policies further supports market expansion in this region.

Nucleic Acid Isolation and Purification Market in United States
The United States dominates the North American nucleic acid isolation market, holding approximately 85% of the regional market share. The country's leadership position is attributed to continuous spending on nucleic acid-based research and various initiatives by market players for advancing genetic research. The presence of major pharmaceutical and biotechnology companies, coupled with substantial research and development activities in genomics and molecular biology, drives market growth. The country's robust healthcare infrastructure, increasing prevalence of genetic disorders, and rising demand for personalized medicine further contribute to market expansion. The strong focus on technological innovations and presence of leading market players makes the United States a key center for nucleic acid isolation and purification market research and development.
Growth Dynamics in United States Nucleic Acid Isolation and Purification Market
The United States is experiencing the fastest growth in North America, with a projected CAGR of approximately 10% from 2024-2029. This growth is driven by increasing investments in genetic research and rising applications in clinical diagnostics. The country's emphasis on precision medicine and genetic testing creates substantial opportunities for market expansion. The growing adoption of automated systems in research laboratories and diagnostic centers further accelerates market growth. Additionally, the rising prevalence of chronic diseases and increasing demand for molecular diagnostic tests contribute to the market's rapid expansion in the United States.
Nucleic Acid Isolation and Purification Market in Europe
The European nucleic acid isolation and purification market showcases significant growth potential, supported by extensive research activities and technological advancements across Germany, the United Kingdom, France, Italy, and Spain. The region benefits from strong government support for genomics research and the presence of leading biotechnology companies. The market is characterized by increasing adoption of automated extraction systems and rising demand for molecular diagnostic testing. Collaborative research initiatives and growing investments in biotechnology further strengthen the market landscape in Europe.
Nucleic Acid Isolation and Purification Market in Germany
Germany leads the European nucleic acid isolation market, commanding approximately 24% of the regional market share. The country's dominant position is supported by its advanced healthcare infrastructure and significant investments in biotechnology research. Germany's leadership in the market is reinforced by the presence of major pharmaceutical companies and research institutions. The country's strong focus on technological innovation and increasing adoption of automated nucleic acid extraction systems in research and diagnostic laboratories contributes to its market leadership. The growing emphasis on personalized medicine and genetic testing further drives market growth in Germany.
Growth Dynamics in United Kingdom Nucleic Acid Isolation and Purification Market
The United Kingdom demonstrates the highest growth rate in Europe, with a projected CAGR of approximately 10% from 2024-2029. The country's growth is driven by increasing investments in genomic research and rising demand for molecular diagnostic testing. The UK's strong focus on research and development in life sciences, coupled with government initiatives supporting genetic research, contributes to market expansion. The presence of leading research institutions and growing adoption of advanced nucleic acid isolation technologies further accelerates market growth. Additionally, the increasing application of nucleic acid-based diagnostics in clinical settings supports the market's rapid development.
Nucleic Acid Isolation and Purification Market in Asia-Pacific
The Asia-Pacific nucleic acid isolation and purification market demonstrates significant growth potential, driven by increasing research activities and rising investments in biotechnology across China, Japan, India, Australia, and South Korea. The region benefits from growing healthcare infrastructure and rising adoption of molecular diagnostic techniques. The market is characterized by increasing research and development activities in genomics and rising demand for automated nucleic acid extraction systems. Government initiatives supporting biotechnology research and growing awareness about genetic testing contribute to market expansion in the region.
Nucleic Acid Isolation and Purification Market in China
China emerges as the largest market in the Asia-Pacific region, driven by substantial investments in biotechnology research and development. The country's market leadership is supported by growing healthcare infrastructure and increasing adoption of molecular diagnostic techniques. China's focus on technological advancement and presence of major research institutions contributes to its market dominance. The country's growing emphasis on precision medicine and genetic research further strengthens its position in the regional market. Additionally, government initiatives supporting biotechnology research and development drive market growth in China.
Growth Dynamics in Indian Nucleic Acid Isolation and Purification Market
India emerges as the fastest-growing market in the Asia-Pacific region, driven by increasing investments in biotechnology research and rising demand for molecular diagnostic testing. The country's growth is supported by improving healthcare infrastructure and growing adoption of advanced nucleic acid isolation technologies. India's expanding research and development activities in genomics and increasing focus on personalized medicine contribute to market growth. The rising prevalence of genetic disorders and growing awareness about molecular diagnostic techniques further accelerate market expansion. Additionally, government initiatives supporting biotechnology research drive the market's rapid development in India.
Nucleic Acid Isolation and Purification Market in Middle East and Africa
The Middle East and Africa market for nucleic acid purification market shows steady growth potential, with significant contributions from GCC countries and South Africa. The region is experiencing increasing adoption of molecular diagnostic techniques and growing investments in healthcare infrastructure. The GCC emerges as the largest market in the region, while South Africa demonstrates significant growth potential. The market benefits from rising awareness about genetic testing and increasing research activities in biotechnology. Government initiatives supporting healthcare infrastructure development and growing investments in research facilities contribute to market expansion in the region.
Nucleic Acid Isolation and Purification Market in South America
The South American nucleic acid isolation and purification market demonstrates promising growth potential, with Brazil and Argentina as key contributing countries. The region is characterized by increasing adoption of molecular diagnostic techniques and growing investments in biotechnology research. Brazil emerges as the largest market in the region, while also showing the fastest growth rate. The market benefits from improving healthcare infrastructure and rising awareness about genetic testing. Government initiatives supporting research and development in biotechnology, coupled with increasing investments in healthcare facilities, drive market growth in the region.
Nucleic Acid Isolation & Purification Industry Overview
Top Companies in Nucleic Acid Isolation and Purification Market
The market is characterized by intense innovation and strategic developments from leading players, including Thermo Fisher Scientific, F. Hoffmann-La Roche, Danaher Corporation, and Bio-Rad Laboratories. Companies are heavily investing in automated systems and magnetic bead-based technologies to enhance efficiency and throughput capabilities in nucleic acid isolation and purification. The competitive landscape shows a strong focus on expanding product portfolios through both internal R&D and strategic acquisitions, particularly in areas like plasmid DNA purification and mRNA isolation. Market leaders are establishing regional manufacturing facilities and research centers to strengthen their global presence while simultaneously developing integrated workflow solutions. There is also an emerging trend of collaborations between established players and biotechnology startups to accelerate technological advancement and market penetration.
Consolidated Market with Strong Global Players
The nucleic acid isolation and purification market exhibits a relatively consolidated structure dominated by large multinational corporations with diverse life sciences portfolios. These major players leverage their extensive distribution networks, established brand reputation, and significant R&D capabilities to maintain their market positions. The landscape is characterized by high entry barriers due to substantial capital requirements, stringent regulatory compliance needs, and the necessity for sophisticated technological expertise. Market consolidation continues through strategic acquisitions, with larger companies actively acquiring innovative startups and smaller specialized firms to enhance their technological capabilities and expand their geographic reach.
The competitive dynamics are shaped by a mix of global conglomerates and specialized biotechnology companies, with regional players maintaining strong positions in specific geographic markets. Major companies are increasingly focusing on vertical integration strategies, controlling everything from raw material production to end-user distribution. The market has witnessed several significant mergers and acquisitions, particularly focused on acquiring novel purification technologies and expanding into emerging markets. Companies are also establishing strategic partnerships with academic institutions and research organizations to strengthen their innovation capabilities and market presence.
Innovation and Customization Drive Future Success
Success in the nucleic acid isolation and purification market increasingly depends on developing customized solutions that address specific end-user requirements while maintaining cost-effectiveness. Incumbent companies are focusing on expanding their automated platform offerings and developing integrated solutions that combine hardware, reagents, and software capabilities. Market leaders are investing in digital capabilities and artificial intelligence to enhance product performance and user experience. Companies are also emphasizing sustainable practices and eco-friendly solutions to align with growing environmental concerns while simultaneously working to reduce the overall cost per test to maintain a competitive advantage.
For emerging players and contenders, success lies in identifying and serving niche market segments with specialized solutions while building strategic partnerships to overcome distribution challenges. Companies need to focus on developing innovative technologies that offer significant advantages over existing methods in terms of speed, accuracy, or cost-effectiveness. The regulatory landscape continues to evolve, particularly regarding quality standards and validation requirements, making regulatory compliance expertise a critical success factor. Market participants must also consider the increasing consolidation among end-users, particularly in the healthcare and research sectors, which affects purchasing patterns and negotiating power.
Nucleic Acid Isolation & Purification Market Leaders
-
Agilent Technologies
-
Bio-Rad Laboratories Inc.
-
Danaher Corporation
-
GE Healthcare
-
Thermo Fisher Scientific
- *Disclaimer: Major Players sorted in no particular order

Nucleic Acid Isolation & Purification Market News
- April 2022: Purigen launched Ionic Cells to Pure DNA Low Input Kit for researchers working with limited biological samples. The simplified and automated 60-minute workflow delivers high-quality DNA for the rapid investigation of genetic abnormalities or examination of disease treatment effects.
- May 2022: Qiagen Inc. launched NeuMoDxHSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2) with approval from the European Commission. This assay's emergence allows the company to expand its product portfolio in laboratory testing, which ultimately helps the market growth owing to the innovative tests.
Nucleic Acid Isolation & Purification Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rapid Technological Advancements
- 4.2.2 Wide-range Applications of Nucleic Acid Testing in Diagnostics
- 4.2.3 Rise in the R&D Funding in Biotechnology
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Professionals
- 4.3.2 Increasing Cost of Automated Instruments
-
4.4 Porter Five Forces
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Technology
- 5.1.1 Column-based Purification
- 5.1.2 Magnetic Bead-based Purification
- 5.1.3 Reagent-based Purification
-
5.2 By Product
- 5.2.1 Kits and Reagents
- 5.2.2 Equipment
- 5.2.3 Other Products
-
5.3 By Application
- 5.3.1 Total RNA Isolation and Purification
- 5.3.2 mRNA Isolation and Purification
- 5.3.3 microRNA Isolation and Purification
- 5.3.4 Plasmid DNA Isolation and Purification
- 5.3.5 Genomic DNA Isolation and Purification
- 5.3.6 Blood DNA Isolation and Purification
- 5.3.7 PCR Clean-up
- 5.3.8 Other Nucleic Acid Isolation and Purification Applications
-
5.4 By End User
- 5.4.1 Hospitals
- 5.4.2 Academic and Research Institutes
- 5.4.3 Pharmaceutical/Biotechnology Industry
- 5.4.4 Other End Users
-
5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Middle East and Africa
- 5.5.4.1 GCC
- 5.5.4.2 South Africa
- 5.5.4.3 Rest of Middle East and Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Agilent Technologies
- 6.1.2 Bio-Rad Laboratories Inc.
- 6.1.3 Thermo Fisher Scientific
- 6.1.4 BioVision Inc.
- 6.1.5 Danaher Corporation
- 6.1.6 F. Hoffmann-La Roche Ltd
- 6.1.7 GE Healthcare
- 6.1.8 Merck KGaA (Sigma-Aldrich Corporation)
- 6.1.9 Promega Corporation
- 6.1.10 Qiagen NV
- 6.1.11 Invitek Molecular
- 6.1.12 Analytik Jena AG
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Nucleic Acid Isolation & Purification Industry Segmentation
As per the scope of the report, nucleic acid isolation is the process by which DNA and/or RNA are separated from proteins, membranes, and other cellular material, and purification removes as much of the additional lipids and proteins from the sample as possible. Nucleic Acids are the key component for many of today's molecular testing methods; therefore, the quality of the isolation step in the process is very important. The Nucleic Acid Isolation and Purification Market are segmented by Technology (Column-based Purification, Magnetic Bead-based Purification, and Reagent-based Purification), Product (Kits and Reagents, Equipment, and Other Products), Application (Total RNA Isolation and Purification, mRNA Isolation and Purification, microRNA Isolation and Purification and Purification and Plasmid DNA Isolation and Purification, Genomic DNA Isolation and Purification, Blood DNA Isolation and Purification, PCR Clean-up, Other Nucleic Acid Isolation, and Purification Applications), End User (Hospitals, Academic and Research Institutes, Pharmaceutical/Biotechnology Industry, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Technology | Column-based Purification | ||
Magnetic Bead-based Purification | |||
Reagent-based Purification | |||
By Product | Kits and Reagents | ||
Equipment | |||
Other Products | |||
By Application | Total RNA Isolation and Purification | ||
mRNA Isolation and Purification | |||
microRNA Isolation and Purification | |||
Plasmid DNA Isolation and Purification | |||
Genomic DNA Isolation and Purification | |||
Blood DNA Isolation and Purification | |||
PCR Clean-up | |||
Other Nucleic Acid Isolation and Purification Applications | |||
By End User | Hospitals | ||
Academic and Research Institutes | |||
Pharmaceutical/Biotechnology Industry | |||
Other End Users | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Nucleic Acid Isolation & Purification Market Research FAQs
How big is the Nucleic Acid Isolation And Purification Market?
The Nucleic Acid Isolation And Purification Market size is expected to reach USD 4.85 billion in 2025 and grow at a CAGR of 8.89% to reach USD 7.42 billion by 2030.
What is the current Nucleic Acid Isolation And Purification Market size?
In 2025, the Nucleic Acid Isolation And Purification Market size is expected to reach USD 4.85 billion.
Who are the key players in Nucleic Acid Isolation And Purification Market?
Agilent Technologies, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare and Thermo Fisher Scientific are the major companies operating in the Nucleic Acid Isolation And Purification Market.
Which is the fastest growing region in Nucleic Acid Isolation And Purification Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Nucleic Acid Isolation And Purification Market?
In 2025, the North America accounts for the largest market share in Nucleic Acid Isolation And Purification Market.
What years does this Nucleic Acid Isolation And Purification Market cover, and what was the market size in 2024?
In 2024, the Nucleic Acid Isolation And Purification Market size was estimated at USD 4.42 billion. The report covers the Nucleic Acid Isolation And Purification Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Nucleic Acid Isolation And Purification Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Nucleic Acid Isolation And Purification Market Research
Mordor Intelligence provides a comprehensive analysis of the nucleic acid isolation and purification market, drawing on our extensive expertise in life sciences research. Our detailed report covers the full range of nucleic acid extraction technologies. This includes methods for DNA RNA isolation, systems for magnetic bead purification, and advanced techniques for plasmid purification. The analysis includes both traditional and emerging approaches to the isolation and purification of nucleic acids. Detailed insights are available in an easy-to-read report PDF format, ready for download.
This strategic report benefits stakeholders by offering an in-depth analysis of nucleic acid extraction and purification technologies. It covers DNA RNA purification systems and viral nucleic acid extraction methodologies. Our research examines various market segments, from nucleic acid biological research reagents to DNA magnetic bead kits. It provides valuable insights into market dynamics and growth opportunities. The report also explores emerging technologies in nucleic acid preparation and protein nucleic acid detection. This gives stakeholders actionable intelligence for informed decision-making in this rapidly evolving sector.